Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

A Long Journey to HCV Cure: Conversations Between Patient and Physician #1

In episode 1 of this ongoing series, listen to a conversation between Stacey Trooskin, MD, PhD, MPH, and patient advocate Brother Dan Palmer on approaches to improve access to HCV therapy and remove barriers to care.
Stacey Trooskin, MD, PhD, MPH
Released: October 19, 2021

Information on this Educational Activity

Faculty

Stacey Trooskin, MD, PhD, MPH

Chief Medical Officer
Philadelphia FIGHT Community Health Centers
Faculty
Division of Infectious Diseases
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania

Stacey Trooskin, MD, PhD, has disclosed that she has received consulting fees and funds for research support from Gilead Sciences.

Program Medium

This program has been made available online.

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Supported by educational grants from
AbbVie
Gilead Sciences, Inc.

Related Content

Complimentary slides from CCO featuring an in-depth analysis of HCV burden and care disparities in specific populations and strategies to reduce disparities.

Released: December 1, 2021

Expert insights on special considerations for individuals with HCV in ethnically diverse populations, from Ahmed M. Elsharkawy PhD, FRCP(UK), and Clinical Care Options (CCO)

person default Ahmed M. Elsharkawy, PhD, FRCP(UK) Released: December 1, 2021

Clinical Care Options (CCO) podcast with Dr. Nancy Reau on new viral hepatitis data from AASLD 2021, including HBV, HCV, and hepatitis delta

Nancy Reau, MD Released: December 1, 2021

Clinical Care Options (CCO) expert analysis by Dr. Stefan Zeuzem on new viral hepatitis data from AASLD 2021, including HBV, HCV, and hepatitis delta

Stefan Zeuzem, MD Released: November 30, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue